Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)

SHE:300702 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	2,970	2,615	2,521	2,651	2,529	2,586
Other Revenue	15.64	15.64	6.74	15.33	16.49	1.37
Revenue	2,986	2,631	2,527	2,667	2,545	2,587
Revenue Growth (YoY)	15.07%	4.10%	-5.23%	4.78%	-1.64%	22.59%
Cost of Revenue	1,879	1,761	1,677	2,076	1,638	1,297
Gross Profit	1,106	869.86	849.83	591.07	907.42	1,290
Selling, General & Admin	552.54	500.32	425.45	423.79	465.02	361.41
Research & Development	238.15	238.9	243.82	231.1	227.4	179.07
Other Operating Expenses	25.43	20.91	28.17	19.72	24.14	26.16
Operating Expenses	816.03	758.76	703.74	670.74	721.58	571.01
Operating Income	290.15	111.1	146.09	-79.67	185.84	719.41
Interest Expense	-13.21	-54.07	-49.91	-33.85	-16.33	-4.41
Interest & Investment Income	3.98	19.88	6.07	7.22	75.73	29.84
Currency Exchange Gain (Loss)	25.18	25.18	8.83	37.92	-10.58	-36.24
Other Non Operating Income (Expenses)	-43.31	-4.85	-2.3	-1.28	-1.12	-1.18
EBT Excluding Unusual Items	262.79	97.24	108.78	-69.66	233.55	707.42
Gain (Loss) on Sale of Investments	-5.39	-30.4	-62.69	-59.65	-12.97	42.64
Gain (Loss) on Sale of Assets	0.37	0.72	-0.03	-0.02	0.06	0.21
Asset Writedown	-72.78	-2.67	-2.09	-8.21	-16.09	-5.51
Other Unusual Items	21.91	13.75	27.64	26.76	13.85	24.13
Pretax Income	206.91	78.64	71.92	-110.5	218.41	768.88
Income Tax Expense	15.16	22.7	44.56	8.37	13.73	101.82
Net Income	191.75	55.94	27.36	-118.87	204.68	667.06
Net Income to Common	191.75	55.94	27.36	-118.87	204.68	667.06
Net Income Growth	339.02%	104.45%	-	-	-69.32%	13.89%
Shares Outstanding (Basic)	347	350	342	350	347	324
Shares Outstanding (Diluted)	347	350	342	350	347	325
Shares Change (YoY)	-0.96%	2.22%	-2.18%	0.78%	6.61%	-0.62%
EPS (Basic)	0.55	0.16	0.08	-0.34	0.59	2.06
EPS (Diluted)	0.55	0.16	0.08	-0.34	0.59	2.05
EPS Growth	343.27%	100.00%	-	-	-71.22%	14.60%
Free Cash Flow	-29.37	175.69	-360.71	-575.71	-998.62	116.13
Free Cash Flow Per Share	-0.09	0.50	-1.05	-1.65	-2.88	0.36
Dividend Per Share	0.050	0.050	0.050	-	0.100	0.278
Dividend Growth	-	-	-	-	-64.00%	-
Gross Margin	37.05%	33.06%	33.63%	22.17%	35.66%	49.87%
Operating Margin	9.72%	4.22%	5.78%	-2.99%	7.30%	27.80%
Profit Margin	6.42%	2.13%	1.08%	-4.46%	8.04%	25.78%
Free Cash Flow Margin	-0.98%	6.68%	-14.27%	-21.59%	-39.24%	4.49%
EBITDA	632.36	432.5	439.74	164.56	371.04	855.5
EBITDA Margin	21.18%	16.44%	17.40%	6.17%	14.58%	33.06%
D&A For EBITDA	342.21	321.4	293.65	244.23	185.2	136.1
EBIT	290.15	111.1	146.09	-79.67	185.84	719.41
EBIT Margin	9.72%	4.22%	5.78%	-2.99%	7.30%	27.80%
Effective Tax Rate	7.32%	28.87%	61.96%	-	6.29%	13.24%
Revenue as Reported	698.6	2,631	2,527	2,667	2,545	2,587
Advertising Expenses	-	61.43	67.59	12.92	0.97	0.87

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.